Veradermics, Inc. (MANE)
102.23
+3.77
(+3.83%)
USD |
NYSE |
Aug 25, 16:00
102.23
0.00 (0.00%)
After-Hours: 19:07
Veradermics Market Cap : 4.271B for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.114B |
| August 21, 2026 | 4.296B |
| August 20, 2026 | 4.400B |
| August 19, 2026 | 4.647B |
| August 18, 2026 | 4.651B |
| August 17, 2026 | 4.521B |
| August 14, 2026 | 4.709B |
| August 13, 2026 | 4.638B |
| August 12, 2026 | 4.556B |
| August 11, 2026 | 4.552B |
| August 10, 2026 | 4.627B |
| August 07, 2026 | 4.779B |
| August 06, 2026 | 4.539B |
| August 05, 2026 | 4.157B |
| August 04, 2026 | 4.006B |
| August 03, 2026 | 3.805B |
| July 31, 2026 | 3.921B |
| July 30, 2026 | 3.907B |
| July 29, 2026 | 4.024B |
| July 28, 2026 | 4.165B |
| July 27, 2026 | 4.160B |
| July 24, 2026 | 4.089B |
| July 23, 2026 | 4.326B |
| July 22, 2026 | 4.102B |
| July 21, 2026 | 4.088B |
| Date | Value |
|---|---|
| July 20, 2026 | 3.960B |
| July 17, 2026 | 4.157B |
| July 16, 2026 | 3.952B |
| July 15, 2026 | 4.619B |
| July 14, 2026 | 4.114B |
| July 13, 2026 | 4.114B |
| July 10, 2026 | 4.466B |
| July 09, 2026 | 4.664B |
| July 08, 2026 | 4.415B |
| July 07, 2026 | 4.361B |
| July 06, 2026 | 4.558B |
| July 02, 2026 | 4.845B |
| July 01, 2026 | 4.797B |
| June 30, 2026 | 4.591B |
| June 29, 2026 | 4.615B |
| June 26, 2026 | 4.738B |
| June 25, 2026 | 4.457B |
| June 24, 2026 | 4.380B |
| June 23, 2026 | 3.868B |
| June 22, 2026 | 3.838B |
| June 18, 2026 | 3.505B |
| June 17, 2026 | 3.430B |
| June 16, 2026 | 3.396B |
| June 15, 2026 | 3.595B |
| June 12, 2026 | 3.587B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.158T |
| EyePoint, Inc. | 425.76M |
| Elanco Animal Health, Inc. | 12.54B |
| Tarsus Pharmaceuticals, Inc. | 3.095B |
| Amylyx Pharmaceuticals, Inc. | 4.172B |
Market Cap Related Metrics
| PEG Ratio | -0.1113 |
| Price to Book Value | 5.246 |
| Price | 102.23 |
| Earnings Yield | -2.55% |
| PEGY Ratio | -0.1113 |